Endeavor

2017–18 Endeavor Catalyst Annual Report

Issue link: http://endeavor.uberflip.com/i/974970

Contents of this Issue

Navigation

Page 65 of 75

6 6 In 2017 alone, Endeavor Catalyst made five new investments into healthcare companies across the globe, joining the two existing investments Endeavor Catalyst had made previously in the space. is mirrors global trends, where sector stakeholders are finding innovative and cost- effective ways to deliver better patient care in the face of rising healthcare costs, a dwindling workforce, and a complex regulatory environment. Over the past 12 months, Endeavor Catalyst has invested in healthcare solutions across the spectrum— addressing innovation both inside and outside of hospitals and medical clinics. Tackling the issue of providing accessible, high-quality healthcare is our first Fund II investment, dr. consulta, a Brazilian network of technology-enabled medical centers. Led by Endeavor Entrepreneurs omaz Srougi and Guilherme Azevedo, DR.CONSULTA has grown from treating 200,000 patients in 8 clinics in 2015 to supporting 1 million+ unique patients in its 50 clinics just in the São Paulo area today. CEO omaz Srougi plans to replicate the model to over 400 medical centers in Brazil by 2022. Another recent investment is VEZEETA—a technology platform that is helping ever busier clinicians not only work hard, but work "smart". Vezeeta is the leading platform for automated physician, clinic, and hospital bookings in Egypt. Led by co-founder and CEO Amir Barsoum, Vezeeta is seeking to build the leading healthcare IT platform in the MENA region. Once a less represented sector within the Endeavor Catalyst portfolio, investments into innovative healthcare companies have been on the rise in the past year. Photo credit: Kieran Kesner H E A LT H C A R E : A R E C E N T WAV E O F I N N O VAT I O N A N D C A P I TA L I N F LO W { Farouk Meralli of mClinica

Articles in this issue

view archives of Endeavor - 2017–18 Endeavor Catalyst Annual Report